Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy : The PROST-QA/RP2 Consortium
PURPOSE: Our goal was to evaluate the comparative effectiveness of robot-assisted laparoscopic prostatectomy (RALP) and open radical prostatectomy (ORP) in a multicenter study.
MATERIALS AND METHODS: We evaluated men with localized prostate cancer at 11 high-volume academic medical centers in the United States from the PROST-QA (2003-2006) and the PROST-QA/RP2 cohorts (2010-2013) with a pre-specified goal of comparing RALP (549) and ORP (545). We measured longitudinal patient-reported health-related quality of life (HRQOL) at pre-treatment and at 2, 6, 12, and 24 months, and pathological and perioperative outcomes/complications.
RESULTS: Demographics, cancer characteristics, and margin status were similar between surgical approaches. ORP subjects were more likely to undergo lymphadenectomy (89% vs 47%; p <0.01) and nerve sparing (94% vs 89%; p <0.01). RALP vs ORP subjects experienced less mean intraoperative blood loss (192 vs 805 mL; p <0.01), shorter mean hospital stay (1.6 vs 2.1 days; p <0.01), and fewer blood transfusions (1% vs 4%; p <0.01), wound infections (2% vs 4%; p=0.02), other infections (1% vs 4%; p <0.01), deep venous thromboses (0.5% vs 2%; p=0.04), and bladder neck contractures requiring dilation (1.6% vs 8.3%; p <0.01). RALP subjects reported less pain (p=0.04), less activity interference (p <0.01) and higher incision satisfaction (p <0.01). Surgical approach (RALP vs ORP) was not a significant predictor of longitudinal HRQOL change in any HRQOL domain.
CONCLUSIONS: In high-volume academic centers, RALP and ORP patients may expect similar long-term HRQOL outcomes. Overall, RALP patients have less pain, shorter hospital stays, and fewer post-surgical complications such as blood transfusions, infections, deep venous thromboses, and bladder neck contractures.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:207 |
---|---|
Enthalten in: |
The Journal of urology - 207(2022), 1 vom: 01. Jan., Seite 127-136 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chang, Peter [VerfasserIn] |
---|
Links: |
---|
Themen: |
Comparative Study |
---|
Anmerkungen: |
Date Completed 20.01.2022 Date Revised 02.01.2023 published: Print-Electronic ClinicalTrials.gov: NCT01325506 Citation Status MEDLINE |
---|
doi: |
10.1097/JU.0000000000002176 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329764713 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329764713 | ||
003 | DE-627 | ||
005 | 20231225205830.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/JU.0000000000002176 |2 doi | |
028 | 5 | 2 | |a pubmed24n1099.xml |
035 | |a (DE-627)NLM329764713 | ||
035 | |a (NLM)34433304 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chang, Peter |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy |b The PROST-QA/RP2 Consortium |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.01.2022 | ||
500 | |a Date Revised 02.01.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a ClinicalTrials.gov: NCT01325506 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a PURPOSE: Our goal was to evaluate the comparative effectiveness of robot-assisted laparoscopic prostatectomy (RALP) and open radical prostatectomy (ORP) in a multicenter study | ||
520 | |a MATERIALS AND METHODS: We evaluated men with localized prostate cancer at 11 high-volume academic medical centers in the United States from the PROST-QA (2003-2006) and the PROST-QA/RP2 cohorts (2010-2013) with a pre-specified goal of comparing RALP (549) and ORP (545). We measured longitudinal patient-reported health-related quality of life (HRQOL) at pre-treatment and at 2, 6, 12, and 24 months, and pathological and perioperative outcomes/complications | ||
520 | |a RESULTS: Demographics, cancer characteristics, and margin status were similar between surgical approaches. ORP subjects were more likely to undergo lymphadenectomy (89% vs 47%; p <0.01) and nerve sparing (94% vs 89%; p <0.01). RALP vs ORP subjects experienced less mean intraoperative blood loss (192 vs 805 mL; p <0.01), shorter mean hospital stay (1.6 vs 2.1 days; p <0.01), and fewer blood transfusions (1% vs 4%; p <0.01), wound infections (2% vs 4%; p=0.02), other infections (1% vs 4%; p <0.01), deep venous thromboses (0.5% vs 2%; p=0.04), and bladder neck contractures requiring dilation (1.6% vs 8.3%; p <0.01). RALP subjects reported less pain (p=0.04), less activity interference (p <0.01) and higher incision satisfaction (p <0.01). Surgical approach (RALP vs ORP) was not a significant predictor of longitudinal HRQOL change in any HRQOL domain | ||
520 | |a CONCLUSIONS: In high-volume academic centers, RALP and ORP patients may expect similar long-term HRQOL outcomes. Overall, RALP patients have less pain, shorter hospital stays, and fewer post-surgical complications such as blood transfusions, infections, deep venous thromboses, and bladder neck contractures | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a prostatectomy | |
650 | 4 | |a quality of life | |
650 | 4 | |a robotic surgical procedures | |
700 | 1 | |a Wagner, Andrew A |e verfasserin |4 aut | |
700 | 1 | |a Regan, Meredith M |e verfasserin |4 aut | |
700 | 1 | |a Smith, Joseph A |e verfasserin |4 aut | |
700 | 1 | |a Saigal, Christopher S |e verfasserin |4 aut | |
700 | 1 | |a Litwin, Mark S |e verfasserin |4 aut | |
700 | 1 | |a Hu, Jim C |e verfasserin |4 aut | |
700 | 1 | |a Cooperberg, Matthew R |e verfasserin |4 aut | |
700 | 1 | |a Carroll, Peter R |e verfasserin |4 aut | |
700 | 1 | |a Klein, Eric A |e verfasserin |4 aut | |
700 | 1 | |a Kibel, Adam S |e verfasserin |4 aut | |
700 | 1 | |a Andriole, Gerald L |e verfasserin |4 aut | |
700 | 1 | |a Han, Misop |e verfasserin |4 aut | |
700 | 1 | |a Partin, Alan W |e verfasserin |4 aut | |
700 | 1 | |a Wood, David P |e verfasserin |4 aut | |
700 | 1 | |a Crociani, Catrina M |e verfasserin |4 aut | |
700 | 1 | |a Greenfield, Thomas K |e verfasserin |4 aut | |
700 | 1 | |a Patil, Dattatraya |e verfasserin |4 aut | |
700 | 1 | |a Hembroff, Larry A |e verfasserin |4 aut | |
700 | 1 | |a Davis, Kyle |e verfasserin |4 aut | |
700 | 1 | |a Stork, Linda |e verfasserin |4 aut | |
700 | 1 | |a Spratt, Daniel E |e verfasserin |4 aut | |
700 | 1 | |a Wei, John T |e verfasserin |4 aut | |
700 | 1 | |a Sanda, Martin G |e verfasserin |4 aut | |
700 | 0 | |a PROST-QA/RP2 Consortium |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of urology |d 1945 |g 207(2022), 1 vom: 01. Jan., Seite 127-136 |w (DE-627)NLM000006890 |x 1527-3792 |7 nnns |
773 | 1 | 8 | |g volume:207 |g year:2022 |g number:1 |g day:01 |g month:01 |g pages:127-136 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/JU.0000000000002176 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 207 |j 2022 |e 1 |b 01 |c 01 |h 127-136 |